Truist Securities Maintains Buy on BKV, Raises Price Target to $34
Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and raises the price target from $33 to $34.
Stocks · News reference
Evercore ISI Group Maintains Outperform on BKV, Lowers Price Target to $32
Evercore ISI Group analyst Chris Baker maintains BKV (NYSE:BKV) with a Outperform and lowers the price target from $33 to $32.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BKV Q2 2026 Earnings Call Transcript
BKV (NYSE:BKV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial
Why Is BKV Stock Surging Wednesday?
BKV stock rises after securing a power equipment deal backed by a major hyperscaler for a 1,200 MW Texas project.
Nasdaq Falls Over 100 Points; US Crude Inventories Decline
U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciences